Drug · DIN 02016109
SURVANTA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 30, 2014; first marketed December 31, 1993.
- Drug Identification Number (DIN)
- 02016109
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Intratracheal
- Therapeutic class (ATC)
- Natural phospholipids R07AA02
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BERACTANT | 25 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 30, 2012: NOC 13921New Drug Submission (NDS) · Manufacturer name change
- December 3, 1997: NOC 3309Supplement to a New Drug Submission (SNDS) · Change in manufacturing
- February 15, 1995: NOC 4896Supplement to a New Drug Submission (SNDS) · Revised product monograph